Vitamin D supplement may enhance dairy cows’ immune health

New research in the Journal of Dairy Science® explores possible genetic effects of dietary supplementation with vitamin D to support cows’ immune function 

 

Known as a crucial component in the body’s ability to absorb and retain calcium, essential to processes such as the development and maintenance of healthy bones, vitamin D has also been found to play important roles in immune defense. A new study in the October issue of the Journal of Dairy Science® explores the effects of different sources and amounts of vitamin D in dairy cows, revealing promising possibilities for improvements to health and welfare.

This study by scientists from the University of Florida, Gainesville (USA), focused on pregnant dairy cows, as pregnancy and lactation increase calcium demands, which might affect calcium reserves of the dam, and such dynamic changes occur when cows are most vulnerable to disease. Thus, it is not surprising that vitamin D could be especially important at this time. “Vitamin D status might contribute to the ability of the immune response to confer resistance to bacterial infections,” states senior author José Eduardo P. Santos, PhD.

In dairy cows, as in humans, vitamin D can be created by the body when skin is exposed to sunlight, or it can be absorbed from dietary sources. Researchers in this study examined dietary supplementation of two different forms of vitamin D, cholecalciferol or calcidiol, at either one or three milligrams above the amount provided in a standard dairy cow diet that contained 0.02 mg of cholecalciferol per kilogram of dry matter. Cholecalciferol is the form of vitamin D typically supplemented in cows’ diets, but Santos notes that the less used form, calcidiol, is one step ahead in the activation of vitamin D and has the potential benefit of maintaining adequate status with smaller daily dietary amounts.

Repeated blood sampling allowed the team to compare circulating concentrations of vitamin D metabolites, minerals and metabolites in blood, and concentrations and activity of white blood cells, which are essential in the body’s ability to respond to infections, such as bacterial invaders that often cause uterine and mammary diseases in cattle. The team also extracted DNA from white blood cells to quantify the expression of several genes related to immune function.

The researchers found that cows supplemented with vitamin D in the form of calcidiol had increased expression of genes that encode for proteins needed for cell adhesion and migration, cell-to-cell communication, pathogen recognition, and pathogen killing compared with those given cholecalciferol. Such changes might enhance the ability of the innate immune system to fend off infections in early lactation.

Santos and colleagues state that, although not conclusive, “The changes observed in this experiment suggest that providing vitamin D beyond the amounts needed to prevent perceived deficiency, in particular by supplementation with calcidiol, might play a role in supporting innate immune defenses in dairy cows.”

Previous work by these researchers showed some indication that calcidiol might affect risk of diseases in early lactation (Martinez et al., 2018; https://doi.org/10.3168/jds.2017-13740), but larger experiments are needed to confirm those results. Although further investigation is needed, the results published in this paper suggest the possibility of another dietary intervention to reduce illness among dairy cows at the risky time around the birth of calves, with positive welfare effects for cows and financial benefits for farmers.

The article is “Effect of source and amount of vitamin D on function and mRNA expression in immune cells in dairy cows,” by Achilles Vieira-Neto, Michael B. Poindexter, Mariana Nehme Marinho, Roney Zimpel, Ali Husnain, Ana Carolina Macedo Silva, Jéssica Glenda Prim, Corwin D. Nelson, and José Eduardo P. Santos (https://doi.org/10.3168/jds.2021-20284). It appears in the Journal of Dairy Science, volume 104, issue 10 (October 2021), published by FASS Inc. and Elsevier.

The Journal of Dairy Science® (JDS), an official journal of the American Dairy Science Association®, is co-published by Elsevier and FASS Inc. for the American Dairy Science Association. It is the leading general dairy research journal in the world. JDS readers represent education, industry, and government agencies in more than 70 countries, with interests in biochemistry, breeding, economics, engineering, environment, food science, genetics, microbiology, nutrition, pathology, physiology, processing, public health, quality assurance, and sanitation. JDS has a 2020 Journal Impact Factor of 4.034 and five-year Journal Impact Factor of 4.354 according to Journal Citation Reports (Source: Clarivate 2021). www.journalofdairyscience.org

The American Dairy Science Association (ADSA) is an international organization of educators, scientists, and industry representatives who are committed to advancing the dairy industry and keenly aware of the vital role the dairy sciences play in fulfilling the economic, nutritive, and health requirements of the world’s population. It provides leadership in scientific and technical support to sustain and grow the global dairy industry through generation, dissemination, and exchange of information and services. Together, ADSA members have discovered new methods and technologies that have revolutionized the dairy industry. www.adsa.org

Since 1998, FASS has provided shared management services to not-for-profit scientific organizations. With combined membership rosters of more than 10,000 professionals in animal agriculture and other sciences, FASS offers clients services in accounting, membership management, convention and meeting planning, information technology, and scientific publication support. The FASS publications department provides journal management, peer-review support, copyediting, and composition for this journal; the staff includes five BELS-certified (www.bels.org) technical editors and experienced composition staff. www.fass.org

As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems.

In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders.

Elsevier employs 8,100 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on our 2,500+ digitized journals, including The Lancet and Cell; our 40,000 eBook titles; and our iconic reference works, such as Gray’s Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.